Literature DB >> 10861683

Are hereditary hemochromatosis mutations involved in Alzheimer disease?

S Moalem1, M E Percy, D F Andrews, T P Kruck, S Wong, A J Dalton, P Mehta, B Fedor, A C Warren.   

Abstract

Mutations in the class I-like major histocompatibility complex gene called HFE are associated with hereditary hemochromatosis (HHC), a disorder of excessive iron uptake. We screened DNA samples from patients with familial Alzheimer disease (FAD) (n = 26), adults with Down syndrome (DS) (n = 50), and older (n = 41) and younger (n = 52) healthy normal individuals, for two HHC point mutations-C282Y and H63D. Because the apolipoprotein E (ApoE) E4 allele is a risk factor for AD and possibly also for dementia of the AD type in DS, DNA samples were also ApoE genotyped. Chi-squared analyses were interpreted at the 0.05 level of significance without Bonferroni corrections. In the pooled healthy normal individuals, C282Y was negatively associated with ApoE E4, an effect also apparent in individuals with DS but not with FAD. Relative to older normals, ApoE E4 was overrepresented in both males and females with FAD, consistent with ApoE E4 being a risk factor for AD; HFE mutations were overrepresented in males and underrepresented in females with FAD. Strong gender effects on the distribution of HFE mutations were apparent in comparisons among ApoE E4 negative individuals in the FAD and healthy normal groups (P < 0.002). Our findings are consistent with the proposition that among ApoE E4 negative individuals HFE mutations are predisposing to FAD in males but are somewhat protective in females. Further, ApoE E4 effects in our FAD group are strongest in females lacking HFE mutations. Relative to younger normals there was a tendency for ApoE E4 and H63D to be overrepresented in males and underrepresented in females with DS. The possibility that HFE mutations are important new genetic risk factors for AD should be pursued further. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10861683     DOI: 10.1002/1096-8628(20000703)93:1<58::aid-ajmg10>3.0.co;2-l

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  21 in total

Review 1.  Iron-chelating backbone coupled with monoamine oxidase inhibitory moiety as novel pluripotential therapeutic agents for Alzheimer's disease: a tribute to Moussa Youdim.

Authors:  Orly Weinreb; Silvia Mandel; Orit Bar-Am; Tamar Amit
Journal:  J Neural Transm (Vienna)       Date:  2011-03-01       Impact factor: 3.575

2.  Association between HFE polymorphisms and susceptibility to Alzheimer's disease: a meta-analysis of 22 studies including 4,365 cases and 8,652 controls.

Authors:  Min Lin; Lin Zhao; Jin Fan; Xue-Gan Lian; Jian-Xin Ye; Lei Wu; Hang Lin
Journal:  Mol Biol Rep       Date:  2011-06-24       Impact factor: 2.316

Review 3.  Brain iron toxicity: differential responses of astrocytes, neurons, and endothelial cells.

Authors:  Julie A Gaasch; Paul R Lockman; Werner J Geldenhuys; David D Allen; Cornelis J Van der Schyf
Journal:  Neurochem Res       Date:  2007-04-03       Impact factor: 3.996

4.  Gender and iron genes may modify associations between brain iron and memory in healthy aging.

Authors:  George Bartzokis; Po H Lu; Kathleen Tingus; Douglas G Peters; Chetan P Amar; Todd A Tishler; J Paul Finn; Pablo Villablanca; Lori L Altshuler; Jim Mintz; Elizabeth Neely; James R Connor
Journal:  Neuropsychopharmacology       Date:  2011-03-09       Impact factor: 7.853

Review 5.  Inherited disorders of transition metal metabolism: an update.

Authors:  Peter T Clayton
Journal:  J Inherit Metab Dis       Date:  2017-03-16       Impact factor: 4.982

6.  Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer's disease.

Authors:  K J H Robson; D J Lehmann; V L C Wimhurst; K J Livesey; M Combrinck; A T Merryweather-Clarke; D R Warden; A D Smith
Journal:  J Med Genet       Date:  2004-04       Impact factor: 6.318

7.  Prevalent iron metabolism gene variants associated with increased brain ferritin iron in healthy older men.

Authors:  George Bartzokis; Po H Lu; Todd A Tishler; Douglas G Peters; Anastasia Kosenko; Katherine A Barrall; J Paul Finn; Pablo Villablanca; Gerhard Laub; Lori L Altshuler; Daniel H Geschwind; Jim Mintz; Elizabeth Neely; James R Connor
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 8.  Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples.

Authors:  Douglas B Kell
Journal:  Arch Toxicol       Date:  2010-08-17       Impact factor: 5.153

9.  Issues raised involving the copper hypotheses in the causation of Alzheimer's disease.

Authors:  George J Brewer
Journal:  Int J Alzheimers Dis       Date:  2011-09-14

10.  Modifying effects of the HFE polymorphisms on the association between lead burden and cognitive decline.

Authors:  Florence T Wang; Howard Hu; Joel Schwartz; Jennifer Weuve; Avron S Spiro; David Sparrow; Huiling Nie; Edwin K Silverman; Scott T Weiss; Robert O Wright
Journal:  Environ Health Perspect       Date:  2007-08       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.